Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

GE Healthcare Launches Flexible Fraction Collector and Sample Pump

Published: Wednesday, May 15, 2013
Last Updated: Wednesday, May 15, 2013
Bookmark and Share
Designed to enhance automation of ÄKTA™ pure protein purification system.

The new fraction collector and sample pump are specifically designed to enhance ÄKTA™ pure, the modular chromatography system for flexible, reliable and intuitive protein purification.

Designed to handle both air and liquid, the sample pump together with the sample inlet valve, provides fast, automated, and complete loading of up to seven samples.

The air-sensor integrated into the valve detects the final drop of sample, automatically preventing the introduction of air whilst ensuring the complete sample reaches the column.

The sample pump also has a robust wash program that removes any air introduced between samples.

In order to secure precious samples from dust and contaminants, the fraction collector is covered and it supports flexible combinations of collection vessels from deep-well plates to 250ml bottles.

In addition to spillage-free collection across the entire flow-rate range of ÄKTA pure, the fraction collector has inbuilt automatic detection of collection vessel type to ensure sample security.

Two videos illustrate the fraction collector and the sample pump:
Fraction collector F9-C:
Sample pump S9 and Sample inlet valve V9-IS:

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Opens USD 7.4 Million APAC Fast Trak Center in South Korea
Center will support South Korea’s rapidly expanding biopharmaceutical industry, helping manufacturers increase production efficiency and speed to market.
Thursday, September 29, 2016
GE to Invest $150M in Biopharma Manufacturing
GE is to invest in a biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT.
Tuesday, September 20, 2016
GE Healthcare, STEMCELL Technologies Announce Agreement
Collaboration aims to provide T-Cell reagents for commercial-scale cell therapy production.
Wednesday, August 24, 2016
GE Healthcare, Sealed Air Announce Agreement
Collaboration aims to deliver film for single-use bioprocess systems.
Thursday, August 18, 2016
GE Healthcare Acquire Biosafe
Acquisition will develop integrated cell therapy and regenerative medicine offering to enable development and patient access to innovative life-saving therapies.
Saturday, July 16, 2016
GE Healthcare Investing in Cures for Cancer
GE’s acquisition of Biosafe Group SA further develops integrated cell therapy and regenerative medicine enabling development and patient access to innovative therapies.
Wednesday, July 13, 2016
GE Healthcare Expands European Capabilities
Expansion will see large volume sterile liquid handling capacity doubled.
Tuesday, April 12, 2016
BeiGene Selects GE’s FlexFactory™ Biomanufacturing Platform
Facility will manufacture biologics for clinical trials.
Wednesday, December 16, 2015
GE Healthcare Licenses CRISPR Gene Engineering Technology Patents
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Tuesday, December 09, 2014
GE Licenses CRISPR Gene Engineering Technology Patents From Broad Institute
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Thursday, December 04, 2014
GE Healthcare and Takeda Join Forces
This alliance is key to enabling the early development of therapeutic drugs through the use of a minimally invasive diagnostic technology.
Thursday, November 13, 2014
GE Healthcare to Collaborate with GlaxoSmithKline on Commercial Oncology Testing
The collaboration aims to improve access to diagnostic testing for cancer patients by establishing a network of clinical laboratories to identify genetic mutations associated with different tumour types.
Tuesday, September 30, 2014
GE Healthcare Life Sciences and Promosome Sign Licensing Agreement
Innovative mammalian cell line development technologies that show promise for increasing manufacturing efficiency of vital biopharmaceuticals.
Tuesday, April 29, 2014
GE Acquires Strategic Assets from Thermo
GE to acquire cell culture media and sera, gene modulation and magnetic beads businesses.
Monday, January 06, 2014
GE Healthcare Acquires Unisyn Medical Technologies’ Transactional Business
The proprietary products and services from Unisyn will be integrated into GE Healthcare’s Global Services organization.
Thursday, May 30, 2013
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
NIH Contributes to Global Effort to Prevent and Manage Lung Diseases
The large scale trial will measure health benefits of clean cookstoves.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos